Surgical Sphincteroplasty Market Growth, Trends and Forecast by 2032

Posted by Ganesh Shinde on January 12th, 2023

According to the most recent report published by Future Market Insights, a leading Market Research firm, the Surgical Sphincteroplasty Market Growth is valued at US$ 1.5 billion and is expected to reach US$ 3.2 billion by the end of 2032 at a CAGR of 7.4%. The forecasted compound annual growth rate is significantly higher than the historical CAGR of 6.1%. Furthermore, the market is expected to provide an absolute dollar opportunity of .6 billion over the next ten years.

Key Takeaways from the Market Study

• The market is expected to grow at a 4% CAGR, which is significantly higher than the 6.1% CAGR recorded in the past.
• By the end of 2032, the global market for Surgical Sphincteroplasty will be worth US$ 3.2 billion.
• The market is expected to offer an absolute dollar opportunity of US$ 1.6 billion between 2022 and 2032.
• Among other segments, the Non-Surgical segment is growing at a CAGR of 2%, whereas its historical growth rate was only 6.1% between 2017 and 2021.
• The U.S. market for Surgical Sphincteroplasty accounts for 35% of the global market. During the forecasted period of 2022 to 2032, it is expected to grow at a CAGR of 2%.
• The Japanese market is expected to grow at the highest CAGR of 1% followed by China at the forecasted rate of 8.3%.

The COVID-19 pandemic prompted stringent lockdown, shortage of healthcare staffs, cancellation of clinical trials and elective surgical procedures, thus moderately hampering the growth of surgical sphincteroplasty market, comments a Future Market Insights analyst.

Read More@ https://www.futuremarketinsights.com/reports/surgical-sphincteroplasty-market

The key competitors in the Surgical Sphincteroplasty Market are:

• Medtronic
• Hill-Rom Services, Inc.
• McKesson
• Braun
• Becton
• Dickinson and Company
• Novo Surgical, Inc.
• Surgical Holdings
• Pelvalon
• Salix Pharmaceutical Inc.
• Johnson & Johnson

The major developments in the Surgical Sphincteroplasty Market are:

• Baxter International Inc. completed the acquisition of Hillrom for US$ 12.5 billion in December 2021 to accelerate its vision of transforming the healthcare sector from hospitals to homes.
• McKesson sold a 30% stake in the German GEHE-Alliance Healthcare Joint Venture to Walgreens Boots Alliance in November 2021. This will result in Walgreens Boots Alliance gaining complete control of the GEHE-Alliance Venture.
• Tissuemed Ltd. was acquired by Becton, Dickinson and Company in December 2021 to advance its existing product portfolio. It will leverage BD's experience and Tissuemed's solid foundation to establish itself as a global leader.